The Nigerian government, in partnership with a multinational healthcare company, Roche and digital healthcare provider, Oncopadi Technologies, has launched the Breast Cancer Access Navigation and Testing (BRANT) Programme—an initiative aimed at supporting breast cancer patients across Nigeria.
The programme aims to enhance early detection and ensure timely, accurate breast cancer diagnosis by offering free immunohistochemistry tests, multidisciplinary care, and navigation services…
Read the full article here
